MedPath

JAMP-EFAVIRENZ

JAMP-EFAVIRENZ

Approved
DIN Number

02458233

Drug Class

Human

Market Date

Jun 14, 2019

Company
HC

Jamp Pharma Corporation

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02458233
AIG Number0137031005
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J05AG03 EFAVIRENZ
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification08:18.08.16
Health Canada Classification

ACTIVE INGREDIENTS (1)

EFAVIRENZActive
Strength: 600 MG
Monograph: EFAVIRENZ

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.